Specialty Drugs Stocks List Ranked for 2024 |

Specialty Drugs ETFs
Recent Specialty Drugs News

Symbol	Grade	Name	% Change
DCTH	C	Delcath Systems, Inc.	8.76
PRTC	C	PureTech Health plc	0.00
RZLT	C	Rezolute, Inc.	3.13
BIIB	D	Biogen Idec Inc.	0.23
CVS	F	CVS Caremark Corporation	0.28
CUE	F	Cue Biopharma, Inc.	-1.72
OPCH	F	Option Care Health, Inc.	-0.20
INZY	F	Inozyme Pharma, Inc.	-2.75
ORIC	F	Oric Pharmaceuticals, Inc.	1.55
OTLK	F	Outlook Therapeutics, Inc.	6.14

View As Page of Charts

Related ETFs - A few ETFs which own one or more of the above listed Specialty Drugs stocks.

Symbol	Grade	Name	Weight
BIS	F	ProShares UltraShort Nasdaq Biotechnology	6.12
PBE	C	PowerShares Dynamic Biotech & Genome	5.07
IBRN	D	iShares Neuroscience and Healthcare ETF	4.68
BBH	B	Market Vectors Biotech ETF	4.58
MNTL	C	Tema Neuroscience and Mental Health ETF	4.26

View all Specialty Drugs ETFs...

Compare ETFs

Compare BBH to MNTL Compare PBE to BBH Compare PBE to MNTL

Specialty Drugs Stocks Recent News

Date	Stock	Title
May 17	BIIB	Ionis, Biogen Down on Ending Development of ALS Drug
May 17	CVS	The Weekly Closeout: Dollar General taps store operations exec as PetSmart searches for a chief toy tester
May 17	CVS	The Medicare Bubble Has Burst
May 17	OTLK	Q2 2024 Outlook Therapeutics Inc Earnings Call
May 16	OPCH	Option Care Health to Participate in Upcoming Investor Conferences
May 16	OTLK	Outlook Therapeutics, Inc. (OTLK) Q2 2024 Earnings Call Transcript
May 16	BIIB	Biogen also drops collaboration with Ionis on Angelman syndrome candidate
May 16	RZLT	Rezolute reports Q3 results
May 16	BIIB	Biogen and Ionis drop ALS candidate after trial setback
May 16	CVS	CVS Health launches new snack brand called Well Market
May 16	BIIB	Biogen, Ionis shelve ALS drug following study failure
May 16	CVS	CVS launches Well Market line of new store-brand products
May 16	BIIB	REFILE-UPDATE 2-Biogen, Ionis to discontinue development of experimental ALS drug
May 16	BIIB	Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
May 16	BIIB	Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
May 16	CVS	CVS Pharmacy® introduces Well Market™, a crave-worthy consumables brand
May 15	OTLK	Outlook Therapeutics reports Q2 results
May 15	OTLK	Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Corporate Update
May 15	RZLT	Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update
May 15	CVS	CVS Health: Secure Dividend And Upside Potential Presents Compelling Opportunity

Specialty Drugs: Specialty drugs are medications that are used to treat complex and chronic conditions, such as cancer, multiple sclerosis, and rheumatoid arthritis. They are typically more expensive than traditional medications and require special handling, storage, and administration. Specialty drugs may also require special monitoring and close follow-up with a healthcare provider.

Browse All Tags